Local expertise for successful compliance in the Nordics, Switzerland, and UK

Market specific solutions

Our local teams of experts in Sweden and Switzerland support affiliates and local companies in several ways. Local intelligence is often necessary to build informed strategies and convincing business cases. We provide the market specific functions needed in pharma and biotech. Explore how we can help you succeed!

How we support you

The Nordic countries

The Nordic countries combine a high level of innovation with strong healthcare systems, making the Nordics a very attractive life science market. Discover how our experienced local team works as an integrated extension of your company across Sweden, Denmark, Finland, Norway and Iceland.

Switzerland

Switzerland represents a highly attractive yet distinct market for life sciences companies. With its own regulatory framework and national requirements, success requires deep understanding of the local regulations. Explore how our experienced team supports your ambitions.

A quaint London street with historic buildings, symbolizing the foundation and enduring heritage of CMC in drug development, ensuring the safety, efficacy, and quality of pharmaceutical products.

The United Kingdom

The United Kingdom remains one of Europe’s most influential and scientifically advanced life sciences markets. However, national requirements, processes and expectations differ from the EU framework. Our experienced specialists navigate the regulatory landscape to support your goals.

More European markets

Through our network of established partners, we offer market specific support across Europe. Read more about our services for pre-approval and post-approval projects.

Your contact person

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.